跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VUMERITY 231 MG CAPSULAS DURAS GASTRORRESISTENTES - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
VUMERITY 231 MG CAPSULAS DURAS GASTRORRESISTENTES
Approved
STANDARD
VUMERITY 231 MG CAPSULAS DURAS GASTRORRESISTENTES
Biogen Netherlands B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 30, 2021
Approval ID
24f374f128f2e5f9
Company
Biogen Netherlands B.V.
Type
Standard
Approval Details
Approval Id
24f374f128f2e5f9
Drug Cima Aemps Name
VUMERITY 231 MG CAPSULAS DURAS GASTRORRESISTENTES
Register Number
1211585001
Holder Company Name
Biogen Netherlands B.V.
Marketing Company Name
Biogen Spain S.L.
Holder Company Detail Path
/organization/biogen-netherlands-bv
Authorization Date
2021-11-30
Dosage Form
CÁPSULA DURA GASTRORRESISTENTE
Dose
231 mg
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Biogen Netherlands B.V.
Company Detail Path
/organization/biogen-netherlands-bv
Company Information
Pharmaceutical Company Name
Biogen Netherlands BV
Country Name
Netherlands
Website
http://www.biogen.nl
Active Ingredients
FUMARATO DE DIROXIMEL
231 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 30, 2021
Approval ID
24f374f128f2e5f9
Type
Standard
Back to CIMA-AEMPS Approvals
